CONMED Price to Free Cash Flow Ratio 2010-2024 | CNMD

Historical price to free cash flow ratio values for CONMED (CNMD) since 2010. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
CONMED Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2024-05-22 74.98 16.68
2024-03-31 80.08 $4.50 17.81
2023-12-31 109.23 $3.37 32.41
2023-09-30 100.42 $1.19 84.65
2023-06-30 135.06 $0.50 268.82
2023-03-31 103.07 $0.22 465.54
2022-12-31 87.78 $0.39 227.70
2022-09-30 79.21 $1.87 42.30
2022-06-30 94.41 $1.78 53.14
2022-03-31 146.14 $2.30 63.55
2021-12-31 139.25 $3.01 46.30
2021-09-30 128.32 $2.64 48.64
2021-06-30 134.58 $3.21 41.92
2021-03-31 127.70 $2.33 54.78
2020-12-31 109.34 $1.75 62.54
2020-09-30 76.66 $2.36 32.44
2020-06-30 69.99 $2.34 29.86
2020-03-31 55.52 $2.85 19.49
2019-12-31 108.11 $2.55 42.48
2019-09-30 92.79 $2.05 45.15
2019-06-30 82.41 $1.57 52.63
2019-03-31 79.92 $1.74 45.91
2018-12-31 61.53 $2.63 23.43
2018-09-30 75.70 $2.27 33.35
2018-03-31 60.20 $2.16 27.89
2017-12-31 48.30 $1.87 25.81
2017-09-30 49.52 $1.60 31.04
2017-06-30 47.89 $2.04 23.49
2017-03-31 41.59 $2.05 20.26
2016-12-31 41.17 $0.90 45.81
2016-09-30 37.17 $0.88 42.43
2016-06-30 44.07 $0.45 98.89
2016-03-31 38.54 $-0.74 0.00
2015-12-31 40.29 $-0.50 0.00
2015-09-30 43.45 $-0.01 0.00
2015-06-30 52.83 $0.03 1567.68
2018-06-30 69.77 $0.86 80.71
2014-12-31 40.46 $1.79 22.58
2014-09-30 33.00 $2.82 11.69
2014-06-30 39.35 $2.81 14.01
2014-03-31 38.56 $3.59 10.73
2013-12-31 37.55 $3.62 10.38
2015-03-31 45.62 $1.83 24.97
2013-09-30 29.85 $2.43 12.26
2013-06-30 27.33 $3.06 8.92
2013-03-31 29.66 $2.62 11.33
2012-12-31 24.23 $3.31 7.32
2012-09-30 24.57 $3.47 7.09
2012-03-31 25.47 $2.45 10.40
2011-12-31 21.78 $2.98 7.30
2011-09-30 19.52 $2.30 8.49
2011-06-30 24.16 $1.75 13.78
2011-03-31 22.29 $1.45 15.42
2010-12-31 22.42 $1.37 16.41
2012-06-30 23.73 $0.76 31.38
2010-09-30 19.01 $-0.02 0.00
2010-06-30 15.80 $-0.00 0.00
2010-03-31 20.20 $-0.41 0.00
2009-12-31 19.34 $0.12 157.25
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.309B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.451B 20.33
Becton Dickinson (BDX) United States $67.758B 19.17
West Pharmaceutical Services (WST) United States $24.351B 43.64
Cardinal Health (CAH) United States $23.460B 13.41
Align Technology (ALGN) United States $19.658B 37.95
Cooper (COO) United States $19.200B 29.05
Labcorp (LH) United States $16.960B 14.60
Henry Schein (HSIC) United States $9.268B 16.49
DENTSPLY SIRONA (XRAY) United States $5.824B 15.08
Merit Medical Systems (MMSI) United States $4.773B 26.16
Patterson (PDCO) United States $2.193B 10.51
STAAR Surgical (STAA) United States $2.091B 80.28
Atrion (ATRI) United States $0.831B 44.36
Lifevantage (LFVN) United States $0.095B 12.25
Pro-Dex (PDEX) United States $0.067B 33.88
Biolase (BIOL) United States $0.006B 0.00